Related Links Educational Materials About Clinical Trials Clinical Trials: Questions and Answers Questions to Ask Your Doctor Drug Information from MedlinePlus

Alternate Title
Basic Trial Information
Trial Description
     Purpose
     Eligibility
     Treatment/Intervention
Trial Contact Information
Registry Information

Alternate Title

Pilot Screening Study for Ovarian Cancer in Participants Who are at High Genetic Risk for Developing Ovarian Cancer

Basic Trial Information

Phase Type Status Age Sponsor Protocol IDs No phase specified Screening Active 30 and over NCI MGH-000084 NCT00039559

Trial Description

Purpose:

Screening tests may help doctors detect cancer cells early and plan more effective treatment for ovarian cancer.

Screening trial to determine the significance of CA 125 levels in detecting ovarian cancer in participants who have a high genetic risk of developing ovarian cancer.

Eligibility:

Eligibility criteria include the following:

• At least 30 years old
• No previous ovarian cancer
• At least 3 months since chemotherapy, radiation therapy, or surgery
• For more information about the eligibility criteria for this trial, refer to the Health Professional version.

Final eligibility for a clinical trial is determined by the health professionals conducting the trial.

Treatment/Intervention:

Blood samples will be collected and patients will complete questionnaires every 3 months for up to 7 years. Some patients may also undergo transvaginal ultrasound. Patients will be evaluated periodically for 1 year after completing the study.

Important:

For more details about this trial, refer to the Health Professional version of the trial summary.

If you are interested in participating in a clinical trial, contact your doctor for a referral or call a trial contact person listed below. You may see the same contact person listed at more than one site, however, if you call the number listed you can ask to speak to the study coordinator or person involved with the specific trial you are interested in. If you have questions about cancer or clinical trials, call the Cancer Information Service at 1-800-4-CANCER (1-800-422-6237). General information about clinical trials, including risks, benefits, and costs, can be found on NCI's Web site.

Trial Contact Information

Trial Lead Organizations

Massachusetts General Hospital

Steven J. Skates, PhD, Protocol chair		Ph: 617-724-9913; 877-726-5130

U.S.A.
California
	Orange
	Chao Family Comprehensive Cancer Center at University of California Irvine Medical Center
		Clinical Trials Office - Chao Family Comprehensive Cancer Center	Ph:  877-UC-STUDY
			Email: ucstudy@uci.edu
Connecticut
	New Haven
	Yale Cancer Center
		Clinical Trials Office - Yale Cancer Center	Ph:  203-785-5702
Iowa
	Des Moines
	John Stoddard Cancer Center at Iowa Methodist Medical Center
		Clinical Trials Office - John Stoddard Cancer Center at Iowa Methodist Medical Center	Ph:  515-241-6727
Massachusetts
	Boston
	Massachusetts General Hospital
		Clinical Trials Office - Massachusetts General Hospital	Ph:  877-726-5130
Nebraska
	Omaha
	Creighton University Medical Center
		Clinical Trials Office - Creighton University Medical Center	Ph:  402-280-4100
North Carolina
	Chapel Hill
	Lineberger Comprehensive Cancer Center at University of North Carolina - Chapel Hill
		Clinical Trials Office - Lineberger Comprehensive Cancer Center	Ph:  877-668-0683; 919-966-4432
	Durham
	Duke Comprehensive Cancer Center
		Clinical Trials Office - Duke Comprehensive Cancer Center	Ph:  888-275-3853
Texas
	Houston
	M. D. Anderson Cancer Center at University of Texas
		Clinical Trials Office - M. D. Anderson Cancer Center at the University of Texas	Ph:  713-792-3245
	San Antonio
	University of Texas Health Science Center at San Antonio
		Maria Romero	Ph:  210-562-1586

Registry Information
Official Title		Ovarian Cancer Screening Pilot Trial in High Risk Women
Trial Start Date		2002-05-14
Registered in ClinicalTrials.gov		NCT00039559
Date Submitted to PDQ		2002-04-17
Information Last Verified		2008-04-04